Diabetes type 1 vaccine - BioSeek

Drug Profile

Diabetes type 1 vaccine - BioSeek

Alternative Names: Insulin B chain vaccine

Latest Information Update: 23 Feb 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of Florida College of Medicine
  • Developer BioSeek; Research Corporation Technologies; University of Florida College of Medicine
  • Class Antihyperglycaemics; Diabetes mellitus vaccines; Vaccines
  • Mechanism of Action Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetes mellitus

Most Recent Events

  • 23 Feb 2004 Discontinued for Diabetes mellitus in USA (unspecified route)
  • 15 Jun 2001 No-Development-Reported for Diabetes mellitus in USA (Unknown route)
  • 20 Aug 1996 A preclinical study has been added to the Diabetes immunogenicity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top